Clinical trial
Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid…
NCT00361036 · Worthington-Kirsch, Robert L., M.D., Other · Completed
Key facts
| NCT number | NCT00361036 |
|---|---|
| Title | Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent |
| Official title | Feasibility Evaluation of the Embolic Agent BeadBlock™ in the Treatment of Uterine Fibroids With Uterine Artery Embolization With Comparison of Study Endpoints to Embosphere® |
| Lead sponsor | Worthington-Kirsch, Robert L., M.D., Other |
| Collaborators | Terumo Medical Corporation Industry Biocompatibles UK Ltd |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leiomyoma, Leiomyomatosis, Uterine Neoplasms |
| Intervention type | Device |
| Interventions | Uterine fibroid embolization BeadBlock™, Uterine fibroid embolization Embosphere® |
| Enrollment | 44 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Aug 7, 2006 |
| Last update posted | Apr 18, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: